There is a sort of ad hoc, DIY version of people trying to make sure that they're getting the right thing, which is that this community of peptide enthusiasts are repeatedly buying from this one person and talking to each other and saying like, Look, I got the right thing
Strength training 23 times per week helps maintain muscle during calorie deficits
For oral semaglutide (Rybelsus), the FDA prescribing information specifically notes increased thyroxine exposure when co-administered with levothyroxine, requiring thyroid parameter monitoring
The question behind the question is usually: "How much longer will I be able to get compounded semaglutide at this price?" The pattern we see: patients conflate three separate timelines: Patent expiration (2031-2033 for the formulations that matter) FDA shortage list removal (expected late 2026 to Q1 2027) Generic market entry (2027 for oral, 2031-2032 for injectable, assuming no patent challenges) The timeline that affects current compounded access is number 2, not number 1
In February 2024, a small number of Ozempic related cases (less than 100) were consolidated into an MDL